SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ:CYTX) (Frankfurt:XMPA) reports financial results for the quarter ended June 30, 2007 and provides an update on recent developments and plans for commercialization.
“Cytori’s three key initiatives this year are to gear up for our 2008 targeted European launch of the Celution™ System for reconstructive surgery market, to advance our cardiovascular disease product pipeline, and to prepare to launch our Celution™ System-based cell bank in Japan,” said Christopher J. Calhoun, chief executive officer. “Significant progress has been made across all areas this year.”
